Nadja West Sells 2,178 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Tenet Healthcare Stock Down 0.4%

THC stock opened at $194.24 on Friday. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $222.82. The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. The company has a market cap of $17.07 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 0.85 and a beta of 1.44. The business’s 50-day simple moving average is $202.87 and its 200 day simple moving average is $186.06.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The company’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the company earned $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors have recently bought and sold shares of the business. AlphaQuest LLC lifted its stake in shares of Tenet Healthcare by 230.8% in the 2nd quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock valued at $310,000 after purchasing an additional 1,230 shares during the period. 111 Capital bought a new stake in Tenet Healthcare in the second quarter valued at about $244,000. Cerity Partners LLC boosted its holdings in Tenet Healthcare by 10.4% during the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after buying an additional 11,395 shares during the last quarter. Royal Bank of Canada grew its position in shares of Tenet Healthcare by 34.0% during the 1st quarter. Royal Bank of Canada now owns 119,349 shares of the company’s stock worth $16,052,000 after buying an additional 30,281 shares during the period. Finally, Leith Wheeler Investment Counsel Ltd. raised its position in shares of Tenet Healthcare by 22.2% in the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 82,813 shares of the company’s stock valued at $14,575,000 after acquiring an additional 15,019 shares during the period. Institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on THC shares. Mizuho boosted their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a report on Friday, October 17th. Royal Bank Of Canada increased their price target on shares of Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Wells Fargo & Company lifted their price objective on Tenet Healthcare from $238.00 to $252.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Weiss Ratings downgraded Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday. Finally, Raymond James Financial set a $245.00 price target on Tenet Healthcare in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $231.81.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.